Sign In
Buy BNR
$8.90
+0.0500 (+0.565%)
At Close: Jul 31, 2026
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Burning Rock Schedules Second Quarter of 2020 Earnings Release on August 11, 2020
01:52am, Tuesday, 21'st Jul 2020
GUANGZHOU, China, July 20, 2020 -- Burning Rock Biotech Limited (NASDAQ: BNR) today announced that it plans to release its unaudited financial results for the second quarter of.
Stocks To Watch: Postmates, Walgreens And Cannabis Plays
08:17am, Saturday, 04'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
On June 29, 2020, Burning Rock Biotech Limited (BNR) announced a strategic partnership with CStone Pharmaceuticals (2616.HK) to co-develop and commercialize companion diagnostics (CDx) for pralsetinib
Burning Rock Announces Full Exercise of Over-Allotment Option in Initial Public Offering
10:30am, Monday, 22'nd Jun 2020
GUANGZHOU, China, June 22, 2020 -- Burning Rock Biotech Limited (“Burning Rock” or the “Company”) (NASDAQ: BNR), a company focused on the application of next generation.
U.S. IPO Weekly Recap: Royalty Pharma Takes The Crown In 5 IPO Week
11:05am, Saturday, 20'th Jun 2020
Five IPOs and one SPAC went public this past week led by Royalty Pharma. Healthcare continued to dominate, with all five IPOs coming from the sector. Seven IPOs
